Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Insulin Glargine
  • Fresno, California
  • +68 more
Sep 6, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, , liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Gratwein, Austria
  • +76 more
Aug 1, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +149 more
Jul 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Worldwide (Glargine, LY2605541)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +166 more
Mar 16, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, glyburide, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +489 more
Nov 27, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • placebo
  • Anaheim, California
  • +86 more
Sep 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Diabetes, Diabetes, Type 2 Trial in Austria, Germany, Switzerland (insulin detemir, insulin aspart, biphasic insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Graz, Austria
  • +126 more
Jun 26, 2017

Diabetes, Type 2 Trial in Worldwide (GSK1614235, Sitagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +8 more
Jun 7, 2017

Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Long Beach, California
  • +330 more
Mar 21, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Alexander City, Alabama
  • +135 more
Mar 8, 2017

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Sulfonylurea, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Miranda, New South Wales, Australia
  • +446 more
Mar 21, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +125 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, insulin detemir, metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alexander City, Alabama
  • +232 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, metformin, glimepiride)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ciudad Autonoma de Bs As, Argentina
  • +189 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin aspart, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Concord, California
  • +123 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (inhaled human insulin, insulin detemir, insulin aspart)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • inhaled human insulin
  • +2 more
  • Campinas, Brazil
  • +72 more
Feb 28, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Bay Minette, Alabama
  • +186 more
Dec 16, 2016

Diabetes, Type 2 Trial in Worldwide (Glimepiride, Canagliflozin (JNJ-28431754), Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Calera, Alabama
  • +141 more
Dec 1, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin glargine
  • Greenbrae, California
  • +95 more
Jan 26, 2017